Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SGYP I suspect that this is going much higher based on the results, price targets, buyout play, comparison to IRWD, and merger finalization.
CALI up thru $3; decent chance this past highflyer gets some january effect movement. highly oversold
LPH yikes: Longwei Petroleum Renews Agreement with RedChip
no, but GPRC now being touted as TRIT sympathy (and of course it's a reverse splitter)
OXGN reverse splitter du-jour. 1/12 r/s brings float down to ~1.6m
AIQ today's reverse splitter. Did a 1/5 r/s and now has float ~ 3.4m. Worth a radar after what DQ (and others) have done.
CLNT patent awarded:
http://finance.yahoo.com/news/cleantech-solutions-receives-patent-production-130000605.html
CLNT has been trending down of late, without a catalyst other than its low float. Today there is a catalyst; let's see how high they take her
CLNT patent awarded:
http://finance.yahoo.com/news/cleantech-solutions-receives-patent-production-130000605.html
CLNT has been trending down of late, without a catalyst other than its low float. Today there is a catalyst; let's see how high they take her.
ATV - still holding shares from a tad higher. Think this one could go substantially higher, but might take a little while. The news from Monday is quite amazing really. Company bought shares from sellers at massive premium, yet still at a discount to cash in the bank. They obviously have a bright outlook for their biz, otherwise it was a poor use of cash.
http://finance.yahoo.com/news/acorn-international-announces-private-purchase-130000199.html
DQ continues ascent on light volume. Starting to see some size bids though. Looking for 8 today
ATV - PR says bought back 2.6m ADSs at 3.30/ADS from persistent sellers. Best part though is that they have 3.87 cash/ADS. I'm a buyer here...big discount to cash, and seller overhang gone.
SHANGHAI, Dec. 24, 2012 /PRNewswire/ -- Acorn International, Inc. (ATV) ("Acorn" or the "Company"), a media and branding company in China engaged in developing, promoting and selling products through extensive direct sales and distribution sales platforms, today announced that it had, through its wholly-owned subsidiary China DRTV, Inc., agreed to purchase via a negotiated transaction a total of 7,859,550 ordinary shares (equivalent to 2,619,850 American Depositary Shares ("ADSs")) in the form of ordinary shares and ADSs from a limited number of former company employees and their affiliates, representing the entire shareholdings in the Company held by such individuals. The purchase price of $1.1 per ordinary share (equivalent to $3.3 per ADS) was established based on, among other factors, a discount of 15.2 % to the Company's cash assets value per share as of September 30, 2012.
The Company entered into the transaction to remove significant selling shareholder overhang with an aim to prevent its trading price from dramatic fluctuation. The transaction was reviewed and approved by Acorn's board of directors (none of whom has an interest in the transaction).
ATV - PR says bought back 2.6m ADSs at 3.30/ADS from persistent sellers. Best part though is that they have 3.87 cash/ADS. I'm a buyer here...big discount to cash, and seller overhang gone.
SHANGHAI, Dec. 24, 2012 /PRNewswire/ -- Acorn International, Inc. (ATV) ("Acorn" or the "Company"), a media and branding company in China engaged in developing, promoting and selling products through extensive direct sales and distribution sales platforms, today announced that it had, through its wholly-owned subsidiary China DRTV, Inc., agreed to purchase via a negotiated transaction a total of 7,859,550 ordinary shares (equivalent to 2,619,850 American Depositary Shares ("ADSs")) in the form of ordinary shares and ADSs from a limited number of former company employees and their affiliates, representing the entire shareholdings in the Company held by such individuals. The purchase price of $1.1 per ordinary share (equivalent to $3.3 per ADS) was established based on, among other factors, a discount of 15.2 % to the Company's cash assets value per share as of September 30, 2012.
The Company entered into the transaction to remove significant selling shareholder overhang with an aim to prevent its trading price from dramatic fluctuation. The transaction was reviewed and approved by Acorn's board of directors (none of whom has an interest in the transaction).
DQ - yep, i still have every share. Waiting for the parabolic move.
DQ - looking forward to a good week for it next week. 1/5 reverse split today makes it quite thin. Hopefully china reverse splitters are still in vogue next week!
DQ at highs; if that holds, sets up nicely for next week. With the r/s mania we had this week, i'm surprised more traders haven't been all over it. Red mkt has something to do with it i think
DQ 1/5 reverse split today. ~2.4m float now. Had they done this a couple days ago, it would be FLYING! lol
STOA - to me, one of the most intriguing parts of this story is the Chinese partnership, where STOA received $500k, and also the equity investment at .15/sh. Not a huge sum by any means, but quite meaningful for a company the size of STOA.
China partnership:
http://finance.yahoo.com/news/sitoa-global-announces-strategic-partnership-120000893.html
Just noticed 8K on CEO change. Let's hope this guy can take us to the next level.
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8621489
the stock wants to move up when the bid isn't constantly getting hit. let's see what happens in the coming weeks.
To me the best part of the DYNT story right now are the comments from the CEO. That sets it above and beyond the likes of AMPL (no catalyst) and even BOSC. Doesn't mean it'll perform like BOSC, but things are definitely looking up for the company
RNIN - yeah, i traded RNIN yesterday, but DYNT has about 1/3 the float of RNIN, although about triple the float of BOSC amazingly
BOSC - yeah, and i sold some right around 13:30 on your chart lol. Figures
DYNT BOSC - with what BOSC continues to do, there's no way i'm selling my DYNT for anything less than a stellar gain. Today is Day#1 only.
I agree that your thinking is rational, but there's a lot of recent evidence that DYNT is a good setup for higher levels. That said, it has dropped below 3 for the time being.
DYNT call me crazy, but this one has what most of the other lowfloat runners didn't have -- very bullish outlook. That's worth something to me. Should go well over 4 i would think.
DYNT - there were no cheap shares available. And with recent price history of the likes of BOSC, CALI, CBMX, etc, sometimes ya just have to pay a bit higher. I did today on DYNT because i love the forward look into Dec. earnings.
DYNT today's reversesplit runner. 1/5 reverse today brings float to 1.6m, and very bullish statements in PR:
http://finance.yahoo.com/news/dynatronics-announces-reverse-stock-split-133500128.html
"Beginning today, we will be operating from that new facility which will allow greater operating efficiencies than our previous facility. In addition, our new SolarisPlus line of therapy devices is being well received by the market. October was a very profitable month for the Company and should result in earnings for the quarter ended December 31st improving significantly over the same period last year."
CLNT - the guys (geoinvesting) that wrote the bullish SA article are noted bears/skeptics most of the time on china stocks. So for them to write a very detailed, bullish report says a lot. Yet the stock has traded down since that article hit SA, and since the PR hit the wires. Maybe they're selling into me, not sure, but i may have to buy more.
It sure is! Of course on the flipside, CLNT had a very nice article written on it, and it's doing nothing. Can't win em all
GPRC another one starting up. recent r/s and wildly profitable. 1.85 here
OPXA r/s biotech from yesterday. Float < 5M.
RNIN just did a 1/5 reverse split yesterday. Maybe not as fun as BOSC, but you can't discount its potential in light of BOSC, CBMX, CALI, CLNT, etc.
GPRC - started accumulating today for next run, whenever that might be.
Interesting macro events going on in china, with some of the growth metrics picking up. But i really like this story from today:
Friday, December 14, 9:20 AM China opens wide the gates to its stock market, ending the $1B limit on stock ownership by overseas sovereign wealth funds and central banks. A rumor this move was coming was likely behind the 4.3% moonshot in Shanghai overnight
Only fly in the ointment right now is the SEC delist risk, which obviously isn't trivial.
TROV - strong close implies that there's a decent chance that the buying pace accelerates tomorrow. That would be nice.
TROV - yeah, nice n steady. Hope it gets parabolic tomorrow.
GGR +40% in talks to be acquired, per article
http://www.globes.co.il/serveen/globes/docview.asp?did=1000806289
CSPI #"s headlines look good, but not so great under the hood (edit)
http://finance.yahoo.com/news/csp-inc-reports-fourth-quarter-133000966.html
that's a pretty compelling article, if its conclusions are true. TROV's setup reminds me in some ways of ROSG, who had a crazy 2012.
TROV The $15 Billion Patent-Play In Trovagene
Compelling article on TROV:
http://seekingalpha.com/article/1060261-the-15-billion-patent-play-in-trovagene?source=email_rt_article_title&ifp=0
Some excerpts:]
Why Trovagene Is The Next Big Patent Play
In 2013, Trovagene will begin to commercialize several urine-based diagnostic tests to screen for cancer and infectious diseases. This company owns a very broad patent estate that covers virtually every use of transrenal molecular testing - cancer diagnosis and monitoring, infectious diseases, prenatal and genetic testing. By 2014, the molecular diagnostics market will be worth $15 Billion, according to Renub Research.
The reason Trovagene is potentially a multi-billion dollar patent-play, rather than simply a diagnostics company, is that its patent position is the equivalent of a monopoly on blood tests performed today to screen for cancers and infectious diseases
If these numbers seem a tad optimistic, consider Exact Sciences (EXAS). This is a development-stage company that is attempting to commercialize a stool-based screening technology for colorectal cancer. The market has valued the company at more than $650 million based upon this one test for one type of cancer. Compare that to Trovagene's multiple-cancer screening technology, a company sporting a $60 million enterprise value. We're either looking at an unfathomable arbitrage opportunity or a tremendous patent play in Trovagene.
Whichever way you look at it, you're dealing with numbers in the billions of dollars. And more importantly, there's an unsurpassable barrier to entry. Trovagene holds the key to potentially billions of dollars in recurring revenue, and the only way in is to lease the key from the company for a fair bit of money ("lease" as in licensing deals).
agree. there is a pesky seller that put a halt on the move. i'm looking for him to be done, and then see what happens
CLNT multiple catalysts for a good pop today. Large China solar subsidies in the news, CLNT insider buys at 3.88/sh, stock down 6 days in a row and low on chart.